Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 153684, 12 pages
http://dx.doi.org/10.1155/2015/153684
Research Article

Germinated Brown Rice Alters Aβ(1-42) Aggregation and Modulates Alzheimer’s Disease-Related Genes in Differentiated Human SH-SY5Y Cells

1Nutricosmeceuticals and Nutrigenomics Programme, Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
4Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia

Received 2 September 2015; Revised 25 November 2015; Accepted 26 November 2015

Academic Editor: Gerald Munch

Copyright © 2015 Nur Hanisah Azmi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Selkoe, E. Mandelkow, and D. Holtzman, “Deciphering alzheimer disease,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, Article ID a011460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. W. P. Esler and M. S. Wolfe, “A portrait of Alzheimer secretases—new features and familiar faces,” Science, vol. 293, no. 5534, pp. 1449–1454, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Parvathy, I. Hussain, E. H. Karran, A. J. Turner, and N. M. Hooper, “Cleavage of Alzheimer's amyloid precursor protein by α-secretase occurs at the surface of neuronal cells,” Biochemistry, vol. 38, no. 30, pp. 9728–9734, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Vassar, B. D. Bennett, S. Babu-Khan et al., “β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE,” Science, vol. 286, no. 5440, pp. 735–741, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Francis, G. McGrath, J. Zhang et al., “aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation,” Developmental Cell, vol. 3, no. 1, pp. 85–97, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. W. T. Kimberly, M. J. LaVoie, B. L. Ostaszewski, W. Ye, M. S. Wolfe, and D. J. Selkoe, “γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6382–6387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Goate, M.-C. Chartier-Harlin, M. Mullan et al., “Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease,” Nature, vol. 349, no. 6311, pp. 704–706, 1991. View at Publisher · View at Google Scholar
  9. D. Scheuner, C. Eckman, M. Jensen et al., “Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease,” Nature Medicine, vol. 2, no. 8, pp. 864–870, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Quiroz-Baez, E. Rojas, and C. Arias, “Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α-, β- and γ-secretase expression,” Neurochemistry International, vol. 55, no. 7, pp. 662–670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tong, W. Zhou, V. Fung et al., “Oxidative stress potentiates BACE1 gene expression and Aβ generation,” Journal of Neural Transmission, vol. 112, no. 3, pp. 455–469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Hébert, K. Horré, L. Nicolaï et al., “Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6415–6420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. P. Mattson, S. W. Barger, B. Cheng, I. Lieberburg, V. L. Smith-Swintosky, and R. E. Rydel, “β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease,” Trends in Neurosciences, vol. 16, no. 10, pp. 409–414, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Nunomura, G. Perry, G. Aliev et al., “Oxidative damage is the earliest event in Alzheimer disease,” Journal of Neuropathology & Experimental Neurology, vol. 60, no. 8, pp. 759–767, 2001. View at Google Scholar · View at Scopus
  15. V. Di Matteo, M. Pierucci, G. Di Giovanni, and E. Esposito, “Prevention and therapy of neurodegenerative disorders: role of nutritional antioxidants,” in Oxidative Stress and Neurodegenerative Disorders, G. A. Qureshi and S. H. Parvez, Eds., pp. 621–661, 2007. View at Google Scholar
  16. M. U. Imam, S. N. A. Musa, N. H. Azmi, and M. Ismail, “Effects of white rice, brown rice and germinated brown rice on antioxidant status of type 2 diabetic rats,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 12952–12969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. I. M. Sani, S. Iqbal, K. W. Chan, and M. Ismail, “Effect of acid and base catalyzed hydrolysis on the yield of phenolics and antioxidant activity of extracts from germinated brown rice (GBR),” Molecules, vol. 17, no. 6, pp. 7584–7594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Ismail, M. Ismail, S. F. Fathy et al., “Neuroprotective effects of germinated brown rice against hydrogen peroxide induced cell death in human SH-SY5Y cells,” International Journal of Molecular Sciences, vol. 13, no. 8, pp. 9692–9708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Soi-Ampornkul, S. Kanyok, S. Junnu et al., “Potent antioxidant and anti-apoptotic activity of pre-germinated brown rice extract against hydrogen peroxide in neuronal SK-N-SH cells: a model of Alzheimer's disease,” Alzheimer's & Dementia, vol. 8, no. 4, supplement, p. P503, 2012. View at Publisher · View at Google Scholar
  20. T. Mamiya, M. Kise, K. Morikawa, H. Aoto, M. Ukai, and Y. Noda, “Effects of pre-germinated brown rice on depression-like behavior in mice,” Pharmacology Biochemistry and Behavior, vol. 86, no. 1, pp. 62–67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Mamiya, T. Asanuma, M. Kise et al., “Effects of pre-germinated brown rice on β-amyloid protein-induced learning and memory deficits in mice,” Biological and Pharmaceutical Bulletin, vol. 27, no. 7, pp. 1041–1045, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Patil and M. K. Khan, “Germinated brown rice as a value added rice product: a review,” Journal of Food Science and Technology, vol. 48, no. 6, pp. 661–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. N. H. Azmi, N. Ismail, M. U. Imam, and M. Ismail, “Ethyl acetate extract of germinated brown rice attenuates hydrogen peroxide-induced oxidative stress in human SH-SY5Y neuroblastoma cells: role of anti-apoptotic, pro-survival and antioxidant genes,” BMC Complementary and Alternative Medicine, vol. 13, no. 1, pp. 177–187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Azlan, M. Ismail, and A. Abdul Hamid, “Extraction and determination of oryzanol in rice bran of mixed herbarium UKMB; AZ 6807: MR 185, AZ 6808: MR 211, AZ6809: MR 29,” ASEAN Food Journal, vol. 15, no. 1, pp. 89–96, 2008. View at Google Scholar
  25. A. R. Rosenkranz, S. Schmaldienst, K. M. Stuhlmeier, W. Chen, W. Knapp, and G. J. Zlabinger, “A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate,” Journal of Immunological Methods, vol. 156, no. 1, pp. 39–45, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. M. U. Imam, N. H. Azmi, M. I. Bhanger, N. Ismail, and M. Ismail, “Antidiabetic properties of germinated brown rice: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 816501, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. U. Imam, M. Ismail, D. J. Ooi et al., “Are bioactive-rich fractions functionally richer?” Critical Reviews in Biotechnology, 2015. View at Publisher · View at Google Scholar
  28. C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Antioxidant properties of phenolic compounds,” Trends in Plant Science, vol. 2, no. 4, pp. 152–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. M. T. Heneka, M. P. Kummer, S. Weggen et al., “Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease,” Current Alzheimer Research, vol. 8, no. 2, pp. 115–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-G. Yang, W.-Y. Wang, T.-J. Ling et al., “Alpha-tocopherol quinone inhibits beta-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines,” Neurochemistry International, vol. 57, no. 8, pp. 914–922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. S. Harvey, I. F. Musgrave, K. S. Ohlsson, A. Fransson, and S. D. Smid, “The green tea polyphenol (−)-epigallocatechin-3-gallate inhibits amyloid-β evoked fibril formation and neuronal cell death in vitro,” Food Chemistry, vol. 129, no. 4, pp. 1729–1736, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Janefjord, J. L. V. Mååg, B. S. Harvey, and S. D. Smid, “Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro,” Cellular and Molecular Neurobiology, vol. 34, no. 1, pp. 31–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Pi, X. Mao, X. Chao et al., “Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo,” PLoS ONE, vol. 7, no. 2, Article ID e31921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Mold, L. Ouro-Gnao, B. M. Wieckowski, and C. Exley, “Copper prevents amyloid-β1−42 from forming amyloid fibrils under near-physiological conditions in vitro,” Scientific Reports, vol. 3, article 1256, 2013. View at Publisher · View at Google Scholar
  35. X. Tian, S. Sui, J. Huang, J.-P. Bai, T.-S. Ren, and Q.-C. Zhao, “Neuroprotective effects of Arctium lappa L. roots against glutamate-induced oxidative stress by inhibiting phosphorylation of p38, JNK and ERK 1/2 MAPKs in PC12 cells,” Environmental Toxicology and Pharmacology, vol. 38, no. 1, pp. 189–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. He, L. Bao, J. Zimering et al., “The protective role of (−)-epigallocatechin-3-gallate in thrombin-induced neuronal cell apoptosis and JNK-MAPK activation,” NeuroReport, vol. 26, no. 7, pp. 416–423, 2015. View at Publisher · View at Google Scholar
  37. H. O. Jauregui, N. T. Hayner, J. L. Driscoll, R. Williams-Holland, M. H. Lipsky, and P. M. Galletti, “Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes—freshly isolated cells, cell suspensions, and primary monolayer cultures,” In Vitro, vol. 17, no. 12, pp. 1100–1110, 1981. View at Publisher · View at Google Scholar · View at Scopus
  38. F. M. LaFerla, K. N. Green, and S. Oddo, “Intracellular amyloid-β in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 8, no. 7, pp. 499–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Dewachter, D. Reversé, N. Caluwaerts et al., “Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice,” The Journal of Neuroscience, vol. 22, no. 9, pp. 3445–3453, 2002. View at Google Scholar · View at Scopus
  40. B. De Strooper, R. Vassar, and T. Golde, “The secretases: enzymes with therapeutic potential in Alzheimer disease,” Nature Reviews Neurology, vol. 6, no. 2, pp. 99–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Cai, Y. Wang, D. McCarthy et al., “BACE1 is the major β-secretase for generation of Aβ peptides by neurons,” Nature Neuroscience, vol. 4, no. 3, pp. 233–234, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Hussain, D. J. Powell, D. R. Howlett et al., “Asp1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site,” Molecular and Cellular Neuroscience, vol. 16, no. 5, pp. 609–619, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Farzan, C. E. Schnitzler, N. Vasilieva, D. Leung, and H. Choe, “BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 17, pp. 9712–9717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. B. D. Bennett, S. Babu-Khan, R. Loeloff et al., “Expression analysis of BACE2 in brain and peripheral tissues,” Journal of Biological Chemistry, vol. 275, no. 27, pp. 20647–20651, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. U. Bodendorf, S. Danner, F. Fischer et al., “Expression of human β-secretase in the mouse brain increases the steady-state level of β-amyloid,” Journal of Neurochemistry, vol. 80, no. 5, pp. 799–806, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Li, K. Lindholm, L.-B. Yang et al., “Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3632–3637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Levites, T. Amit, S. Mandel, and M. B. Youdim, “Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate,” The FASEB Journal, vol. 17, no. 8, pp. 952–954, 2003. View at Publisher · View at Google Scholar
  48. R. Postina, A. Schroeder, I. Dewachter et al., “A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model,” Journal of Clinical Investigation, vol. 113, no. 10, pp. 1456–1464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Herz and D. K. Strickland, “LRP: a multifunctional scavenger and signaling receptor,” The Journal of Clinical Investigation, vol. 108, no. 6, pp. 779–784, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Shibata, S. Yamada, S. Ram Kumar et al., “Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier,” Journal of Clinical Investigation, vol. 106, no. 12, pp. 1489–1499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Deane, A. Sagare, K. Hamm et al., “IgG-assisted age-dependent clearance of Alzheimer's amyloid β peptide by the blood-brain barrier neonatal Fc receptor,” The Journal of Neuroscience, vol. 25, no. 50, pp. 11495–11503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. B. V. Zlokovic, “Cerebrovascular transport of Alzheimer's amyloid β and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier,” Life Sciences, vol. 59, no. 18, pp. 1483–1497, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. B. V. Zlokovic, “New therapeutic targets in the neurovascular pathway in Alzheimer’s disease,” Neurotherapeutics, vol. 5, no. 3, pp. 409–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. B. V. Zlokovic, R. Deane, A. P. Sagare, R. D. Bell, and E. A. Winkler, “Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain,” Journal of Neurochemistry, vol. 115, no. 5, pp. 1077–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Carrano, J. J. M. Hoozemans, S. M. van der Vies, A. J. M. Rozemuller, J. van Horssen, and H. E. de Vries, “Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy,” Antioxidants and Redox Signaling, vol. 15, no. 5, pp. 1167–1178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Iwata, S. Tsubuki, Y. Takaki et al., “Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition,” Nature Medicine, vol. 6, no. 2, pp. 143–150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Yasojima, H. Akiyama, E. G. McGeer, and P. L. McGeer, “Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide,” Neuroscience Letters, vol. 297, no. 2, pp. 97–100, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Iwata, S. Tsubuki, Y. Takaki et al., “Metabolic regulation of brain Aβ by neprilysin,” Science, vol. 292, no. 5521, pp. 1550–1552, 2001. View at Publisher · View at Google Scholar · View at Scopus